Winslow Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,270,590
| Closed | -$487M | – | 64 |
|
|
2024
Q2 | $487M | Buy |
5,270,590
+211,858
| +4% | +$19.6M | 1.76% | 18 |
|
|
2024
Q1 | $483M | Buy |
+5,058,732
| New | +$483M | 1.82% | 17 |
|
|
2021
Q4 | – | Sell |
-2,305,015
| Closed | -$261M | – | 69 |
|
|
2021
Q3 | $261M | Sell |
2,305,015
-1,020,308
| -31% | -$116M | 1.02% | 40 |
|
|
2021
Q2 | $344M | Buy |
3,325,323
+298,794
| +10% | +$30.9M | 1.34% | 27 |
|
|
2021
Q1 | $253M | Buy |
3,026,529
+2,878,877
| +1,950% | +$241M | 1.07% | 37 |
|
|
2020
Q4 | $13.5M | Buy |
+147,652
| New | +$13.5M | 0.06% | 52 |
|
|
2019
Q1 | – | Sell |
-1,320
| Closed | -$202K | – | 80 |
|
|
2018
Q4 | $202K | Sell |
1,320
-1,410,450
| -100% | -$216M | ﹤0.01% | 66 |
|
|
2018
Q3 | $246M | Sell |
1,411,770
-257,505
| -15% | -$44.8M | 1.22% | 39 |
|
|
2018
Q2 | $243M | Sell |
1,669,275
-326,441
| -16% | -$47.5M | 1.27% | 37 |
|
|
2018
Q1 | $278M | Sell |
1,995,716
-89,928
| -4% | -$12.5M | 1.51% | 26 |
|
|
2017
Q4 | $235M | Buy |
2,085,644
+457,764
| +28% | +$51.6M | 1.29% | 34 |
|
|
2017
Q3 | $178M | Sell |
1,627,880
-597,451
| -27% | -$65.3M | 0.96% | 54 |
|
|
2017
Q2 | $263M | Sell |
2,225,331
-429,153
| -16% | -$50.7M | 1.4% | 28 |
|
|
2017
Q1 | $250M | Buy |
2,654,484
+19,887
| +0.8% | +$1.87M | 1.19% | 37 |
|
|
2016
Q4 | $247M | Buy |
2,634,597
+2,634,526
| +3,710,600% | +$247M | 1.14% | 41 |
|
|
2016
Q3 | $9K | Buy |
+71
| New | +$9K | ﹤0.01% | 147 |
|
|
2016
Q2 | – | Sell |
-2,454,726
| Closed | -$217M | – | 143 |
|
|
2016
Q1 | $217M | Sell |
2,454,726
-1,101,493
| -31% | -$97.2M | 0.85% | 58 |
|
|
2015
Q4 | $281M | Buy |
3,556,219
+1,494,287
| +72% | +$118M | 1% | 45 |
|
|
2015
Q3 | $293M | Buy |
+2,061,932
| New | +$293M | 1.07% | 44 |
|